In January 2017, Deerfield and MD Anderson Cancer Center entered into a strategic collaboration to form Vescor Therapeutics. Vescor is focused on discovery and development of autophagy targeted therapeutics for cancer treatment. Autophagy is a cellular process that plays an important role during the development and maintenance of tumors. It allows tumors to scavenge nutrients to sustain growth and survival. Autophagy also has been demonstrated as critical to therapeutic resistance, and is upregulated during cancer treatment in response to chemotherapy and radiation.